PROCESSA PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.22 USD | +1.83% |
|
+37.04% | -66.83% |
Chart calendar Processa Pharmaceuticals, Inc.
7dd8c55e.R4gkYug5tJ99Dz4XnhI2TOt6e7_luruTFFT0LgkHFRc.IMRjLYFz8_IoZUhd9yVGJYhKAfSp-OrjQwCXd21uemcF40xbqQnX9BxWew~931b0bb40cdfc8656157491a9395620d
Upcoming events on Processa Pharmaceuticals, Inc.
No events available
Past events on Processa Pharmaceuticals, Inc.
| 2024-04-09 12:00 pm | American Association for Cancer Research Meeting - Poster No: 23 |
| 2024-04-08 04:30 pm | American Association for Cancer Research Meeting - Poster No: 11 |
| 2024-04-03 10:55 am | MedInvest Biotech & Pharma Investor Conference |
| 2024-02-26 10:00 am | BIO CEO & Investor Conference |
| 2024-02-20 01:30 pm | Winter Wrap-Up MicroCap Rodeo Virtual Investor Conference |
| 2024-01-08 | Biotech Showcase |
| 2023-12-20 04:30 pm | Business Update Call |
| 2023-12-05 04:35 pm | MedInvest Oncology Investor Conference |
| 2023-11-16 02:40 pm | Paradigm Orphan Drugs & Rare Diseases Global Congress |
| 2023-11-14 01:00 pm | Extraordinary Shareholders Meeting |
| 2023-10-19 04:30 pm | ThinkEquity Conference |
| 2023-09-13 03:30 pm | H.C. Wainwright Global Investment Conference |
| 2023-08-17 11:30 am | Sidoti Micro Cap Conference |
| 2023-06-27 12:00 pm | Annual General Meeting |
| 2023-06-21 12:00 pm | MedInvest Oncology Investor Conference |
| 2023-05-24 04:20 pm | World Orphan Drug Congress - Panel |
| 2023-05-06 03:00 pm | Digestive Disease Week |
| 2023-03-30 04:30 pm | Q4 2022 Earnings Call |
| 2023-03-30 04:01 pm | Q4 2022 Earnings Release |
| 2023-03-14 12:00 pm | Oppenheimer Healthcare Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -6,44 -5,62 -14.64% | -11,6 -11,5 -0.57% | -20,3 -20,8 2.6% | -11,5 -11,2 -2.63% | -11,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -15,4 -8,56 -80.17% | -12,0 -11,6 -2.98% | -27,4 -20,8 -32.16% | -11,1 -10,9 -2.1% | -11,0 |
|
Net income Million USD | Released Forecast Spread | -14,4 -8,20 -75.8% | -11,4 -11,4 -0.48% | -27,4 -20,8 -32.16% | -11,1 -10,9 -2.1% | -12,6 |
|
EPS USD | Released Forecast Spread | -50,8 -26,3 -93.16% | -15,0 -14,8 -1.35% | -34,0 -24,3 -39.73% | -8,48 -8,50 0.24% | -3,82 |
| Announcement Date | 25/03/21 | 30/03/22 | 30/03/23 | 29/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | |
|
EBIT Million USD | Released Forecast Spread | -3,37 -3,02 -11.56% | -3,23 -3,47 6.84% | -5,17 -3,26 -58.89% | -6,06 -5,39 -12.43% | -5,80 -6,34 8.51% | -4,11 -5,75 28.6% | -2,71 -3,77 27.92% | -2,17 -2,75 21.24% | -2,47 -2,18 -13.49% | -2,55 | -2,65 | -2,90 | -3,20 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,37 -3,02 -11.48% | -3,23 -3,46 6.86% | -5,16 -3,25 -58.71% | -6,02 -5,39 -11.75% | -13,0 -6,34 -105.27% | -4,02 -5,75 30.05% | -2,61 -3,77 30.63% | -2,08 -2,75 24.35% | -2,40 -2,18 -10.52% | -2,46 | -2,57 | -2,84 | -3,09 | |
|
Net income Million USD | Released Forecast Spread | -3,18 -2,95 -7.76% | -3,23 -3,41 5.46% | -5,16 -3,11 -66.22% | -6,02 -5,39 -11.75% | -13,0 -6,34 -105.27% | -4,02 -5,75 30.05% | -2,61 -3,77 30.63% | -2,08 -2,75 24.35% | -2,40 -2,18 -10.52% | |||||
|
EPS USD | Released Forecast Spread | -4,20 -3,80 -10.53% | -4,00 -4,27 6.25% | -6,40 -4,07 -57.38% | -7,40 -6,73 -9.9% | -16,0 -6,40 -150% | -3,60 -5,60 35.71% | -2,00 -3,00 33.33% | -1,60 -2,00 20% | -8,14 -1,60 -408.75% | -1,18 | -0,90 | -0,99 | -0,84 | -0,56 |
| Announcement Date | 30/03/22 | 12/05/22 | 11/08/22 | 08/11/22 | 30/03/23 | 15/05/23 | 10/08/23 | 13/11/23 | 29/03/24 | - | - | - | - | - |
More events
Past sector events for Processa Pharmaceuticals, Inc.
| Today | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
| Today | AMGEN INC.: Q1 2024 Earnings Release |
| 2024-05-01 04:05 pm | CORCEPT THERAPEUTICS INCORPORATED: Q1 2024 Earnings Release |
| 2024-05-01 04:05 pm | JAZZ PHARMACEUTICALS PLC: Q1 2024 Earnings Release |
| 2024-05-01 06:45 am | PFIZER, INC.: Q1 2024 Earnings Release |
| 2024-05-01 03:00 am | HALEON PLC: Q1 2024 Sales and Revenue Release - Trading Statement |
| 2024-05-01 02:00 am | GSK PLC: Q1 2024 Earnings Release |
| 2024-04-30 | INNOVIVA, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | PACIRA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | EYEPOINT PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PCSA Stock
- Calendar Processa Pharmaceuticals, Inc.
